# Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease

Study · id `cardio:ct-nct06203236` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06203236](<https://clinicaltrials.gov/study/NCT06203236>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06203236

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT06203236. Randomized; double masking; primary purpose treatment. Start 2024-01 (anticipated); primary completion 2025-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT06203236, source copy `cardio:ctgov-nct06203236-2024-01-12`, retrieved 2026-10-26)
- Planned start: 2024-01 (anticipated) (ClinicalTrials.gov record NCT06203236, source copy `cardio:ctgov-nct06203236-2024-01-12`, retrieved 2026-10-26)
- Primary completion: 2025-03 (anticipated) (ClinicalTrials.gov record NCT06203236, source copy `cardio:ctgov-nct06203236-2024-01-12`, retrieved 2026-10-26)
- Completion: 2025-11 (anticipated) (ClinicalTrials.gov record NCT06203236, source copy `cardio:ctgov-nct06203236-2024-01-12`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06203236-2024-01-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
- Condition: Acute Heart Failure
- Condition: Chronic Kidney Diseases
- Intervention (Drug): Furosemide 20 MG
- Intervention (Other): diuretic therapy
- Lead sponsor: Assiut University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Assiut University (`cardio:org-assiut-university`)

## Provenance

Content hash: de797974892f664dcfea4d0a260e72dc3b6924b763dbe7c92a82a2f2a52d3a7b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
